AI-enabled precision medicine combining genomic testing with clinical data.
Healthcare and life sciences technology
About
Tempus AI is a precision medicine company founded in Chicago in 2015 by Eric Lefkofsky, who is chief executive. It combines genomic sequencing and other diagnostic tests with a large library of clinical and molecular data, and uses AI to support treatment decisions for physicians and drug discovery and development for life sciences companies. Tempus is listed on Nasdaq and reported 2025 revenue of $1.27 billion. At the end of 2025 it had data agreements with more than 70 pharmaceutical customers worth over $1.1 billion in total contract value.
Key facts
Headquarters
Chicago, United States
Founded
2015
Chief executive
Eric Lefkofsky
Founders
Eric Lefkofsky
Regions served
United States
Markets
Healthcare and life sciences technology
Website
tempus.com
Products and solutions
Genomic and diagnostic testing
Clinical and molecular data for research
Cookies on ConfX We use cookies that are necessary for this website to function. With your consent, we also use analytics and marketing cookies to understand how the website is used and to measure our campaigns. Cookie Policy
Strictly necessarySecurity, sign-in, live chat and your cookie choices.Always on
confxglobal.com
Event sponsorship
Request sponsorship details
Tell us which event interests you and our team will send the options and pricing.
DemandGen Program
Discuss a program
Describe the audience you want to reach and your goals.
Bespoke events
Plan a bespoke event
Conferences, roundtable series, customer summits and hospitality events, designed and delivered for you.
Contact
Send us a message
Questions about ConfX, our events, research or your account.
Register interest
Knowledge Sessions
Watch every session with a ConfX account
Keynotes, panels and fireside chats from ConfX events, plus full research reports and tools you can save.